# Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma

> **NCT02928289** · NA · TERMINATED · sponsor: **Sight Sciences, Inc.** · enrollment: 29 (actual)

## Conditions studied

- Open-Angle Glaucoma

## Interventions

- **DEVICE:** VISCO360 ab interno canaloplasty surgery
- **DEVICE:** Selective Laser Trabeculoplasty (SLT)

## Key facts

- **NCT ID:** NCT02928289
- **Lead sponsor:** Sight Sciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-23
- **Primary completion:** 2019-01-17
- **Final completion:** 2019-01-17
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Poor enrollment
- **Last updated:** 2025-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02928289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02928289, "Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02928289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*